Seegene, Foreign Investors Net Buy 77,452 Shares in Last 5 Days... Stock Price 205,500 KRW (-1.72%)

As of 11:31 AM on the 21st, Seegene is trading at 205,500 KRW, down 1.72% from the previous day. The trading volume is 297,269 shares, which is 57.51% of the previous day's volume. Seegene is known as a developer, manufacturer, and seller of molecular diagnostic reagents.

On December 17, Hana Financial Investment researcher Sun Min-jung stated, "November's diagnostic kit export amount reached an all-time high. The diagnostic setup established by Seegene automates the entire process from nucleic acid extraction to gene amplification and final data output, enabling fast and prompt results. Thanks to this convenience and accuracy, equipment sales have been steadily generated, and the increase in equipment sales has led to an increase in reagent sales, allowing Seegene's diagnostic kit exports to maintain high growth. They are also developing a COVID-19 virus diagnostic kit with increased sensitivity suitable for saliva testing." She set Seegene's target price at 370,000 KRW.

Over the past five days, individual investors have net sold 68,475 shares of Seegene, while foreigners and institutions have net bought 77,452 shares and net sold 8,798 shares, respectively.

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.